Evidence map›Paper›PMID 37339137›Full record

ArticlePLoS computational biology2023

Modeling the sequence dependence of differential antibody binding in the immune response to infectious disease.

Robayet Chowdhury, Alexander T Taguchi, Laimonas Kelbauskas, Phillip Stafford, Chris Diehnelt, Zhan-Gong Zhao, Phillip C Williamson, Valerie Green, Neal W Woodbury

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Robayet ChowdhuryCenter for Innovations in Medicine, Biodesign Institute, Arizona State University, Tempe, Arizona, United States of America.
Alexander T TaguchiiBio Inc., San Diego, California, United States of America.
Laimonas KelbauskasCenter for Innovations in Medicine, Biodesign Institute, Arizona State University, Tempe, Arizona, United States of America.ORCID 0000-0002-9035-1642
Phillip StaffordCenter for Innovations in Medicine, Biodesign Institute, Arizona State University, Tempe, Arizona, United States of America.
Chris DiehneltCenter for Innovations in Medicine, Biodesign Institute, Arizona State University, Tempe, Arizona, United States of America.
Zhan-Gong ZhaoCenter for Innovations in Medicine, Biodesign Institute, Arizona State University, Tempe, Arizona, United States of America.
Phillip C WilliamsonCreative Testing Solutions, Tempe, Arizona, United States of America.
Valerie GreenCreative Testing Solutions, Tempe, Arizona, United States of America.
Neal W WoodburyCenter for Innovations in Medicine, Biodesign Institute, Arizona State University, Tempe, Arizona, United States of America.
Center for Innovation · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Past studies have shown that incubation of human serum samples on high density peptide arrays followed by measurement of total antibody bound to each peptide sequence allows detection and discrimination of humoral immune responses to a variety of infectious diseases. This is true even though these arrays consist of peptides with near-random amino acid sequences that were not designed to mimic biological antigens. This "immunosignature" approach, is based on a statistical evaluation of the binding pattern for each sample but it ignores the information contained in the amino acid sequences that the antibodies are binding to. Here, similar array-based antibody profiles are instead used to train a neural network to model the sequence dependence of molecular recognition involved in the immune response of each sample. The binding profiles used resulted from incubating serum from 5 infectious disease cohorts (Hepatitis B and C, Dengue Fever, West Nile Virus and Chagas disease) and an uninfected cohort with 122,926 peptide sequences on an array. These sequences were selected quasi-randomly to represent an even but sparse sample of the entire possible combinatorial sequence space (~1012). This very sparse sampling of combinatorial sequence space was sufficient to capture a statistically accurate representation of the humoral immune response across the entire space. Processing array data using the neural network not only captures the disease-specific sequence-binding information but aggregates binding information with respect to sequence, removing sequence-independent noise and improving the accuracy of array-based classification of disease compared with the raw binding data. Because the neural network model is trained on all samples simultaneously, a highly condensed representation of the differential information between samples resides in the output layer of the model, and the column vectors from this layer can be used to represent each sample for classification or unsupervised clustering applications.

Indexed as

AntibodiesCommunicable DiseasesAmino Acid SequenceHumansImmunityPeptidesAntibodiesPeptides

Identifiers

PMID37339137
PMCPMC10313026
OpenAlexW4381432283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.